Pharmaceutical Business Investment Opportunities

Operates as a pharmaceutical manufacturing company in Ahmedabad producing cardiac-diabetic, psychotropic, neuro, and antibiotic medicines. - Serves 300+ clients across India through a cash-based business model supported by 25+ years of promoter experience. - Manufactures products under its own brand and also undertakes contract manufacturing for 12–15 companies. - Generates around 80% of revenue from its branded medicines and the remaining 20% from contract manufacturing. - Supplies products to 150+ multi-specialty hospitals across Gujarat and Maharashtra and fulfills government tenders in both states. - Drop in sales as the owner was busy, and was not able to dedicate enough time to the business. - Holds GMP, GLP, GDP, and ISO certifications along with valid GST registration and a manufacturing license.

Tech-enabled B2B pharmaceutical distribution platform, focusing on simplifying pharmacy procurement from over 50 distributors. - 2,000+ pharmacies served till date. - Revenue model: 8-10% EBITDA margin on B2B sales, projected to grow. - Promoters: Founder (Forbes 30 under 30 Asia, IIT Bombay, Y-Combinator) and Co-Founder (25 years pharma distribution experience). - Backed by Bluewatch Ventures, Soma Capital, Enrission India Capital, and Goodwater. - $4.2M seed funding raised (3 years ago). - 150+ pharma brands integrated. - Business has a registration and distribution license.

This global biotechnology company specializes in cutting-edge allogeneic adult stem cell technology, uniquely positioned as the only FDA-approved entity worldwide, with the Drug Controller General of India (DCGI) approval in process. - The company manufactures clinical-grade stem cells under cGMP standards, providing vital materials for US-based and international clinical trials, hence establishing a strong foothold in the biotechnology sector. - With Investigational New Drug Approvals for several serious conditions, including acute myocardial infarction, chronic heart failure, and Alzheimer’s disease, the company focuses on innovative solutions for chronic ailments lacking effective treatments. - Its cell-based therapies are designed to enhance longevity and quality of life, particularly targeting rehabilitation for chronic stroke patients and those affected by diseases without available cures. - Operating for 24 years in California, the business has a robust track record and is actively seeking expansion opportunities in international markets, allowing for broader reach and impact. - Revenue is generated through multiple channels, including a sale of license model with annual royalty fees averaging around 15% revenue, alongside direct sales of stem cells to existing licensees that partner with hospitals and healthcare providers. - Major license sale deals over the years include up to $18 million (₹162.7 crore) with a Chinese firm, $28 million (₹253 crore) with a Mexican company, $20 million (₹180.7 crore) with a Russian entity, and $21 million (₹189.8 crore) with a Kazakh company, showcasing strong demand and financial viability. - Recently registered as a public limited company in India, the firm is planning to establish a local laboratory and operations, further strengthening its market presence in the biotechnology industry. - The workforce comprises around 50 full-time employees, supplemented by freelance and interns, enhancing operational flexibility and innovation in research and development. - The promoter is currently in India and oversees operations across both locations.

This global biotechnology company specializes in cutting-edge allogeneic adult stem cell technology, uniquely positioned as the only FDA-approved entity worldwide, with the Drug Controller General of India (DCGI) approval in process. - The company manufactures clinical-grade stem cells under cGMP standards, providing vital materials for US-based and international clinical trials, hence establishing a strong foothold in the biotechnology sector. - With Investigational New Drug Approvals for several serious conditions, including acute myocardial infarction, chronic heart failure, and Alzheimer’s disease, the company focuses on innovative solutions for chronic ailments lacking effective treatments. - Its cell-based therapies are designed to enhance longevity and quality of life, particularly targeting rehabilitation for chronic stroke patients and those affected by diseases without available cures. - Operating for 24 years in California, the business has a robust track record and is actively seeking expansion opportunities in international markets, allowing for broader reach and impact. - Revenue is generated through multiple channels, including a sale of license model with annual royalty fees averaging around 15% revenue, alongside direct sales of stem cells to existing licensees that partner with hospitals and healthcare providers. - Major license sale deals over the years include up to $18 million (₹162.7 crore) with a Chinese firm, $28 million (₹253 crore) with a Mexican company, $20 million (₹180.7 crore) with a Russian entity, and $21 million (₹189.8 crore) with a Kazakh company, showcasing strong demand and financial viability. - Recently registered as a public limited company in India, the firm is planning to establish a local laboratory and operations, further strengthening its market presence in the biotechnology industry. - The workforce comprises around 50 full-time employees, supplemented by freelance and interns, enhancing operational flexibility and innovation in research and development. - The promoter is currently in India and oversees operations across both locations.

Our venture operates a dual-channel revenue model through Shopify D2C and EU-based pharmacy/retail B2B, supported by a 3PL logistics hub in Brno. We serve an expanding base of early adopters across Europe and New Zealand, with a projected year-1 capacity to scale to 15,000 customers through digital acquisition and pharmacy distribution. We operate on a fully compliant, asset-light supply chain model, with the following foundations already in place: EU compliance completed (CPSR/CPNP) Responsible Person (RP) structure established. Unique New Zealand ingredient IP. GMP-certified contract manufacturing partners. Active market preparation and channel development. D2C Shopify and pharmacy/retail B2B distribution. Founder expertise: 20+ years in procurement, supply chain, GMP/ISO implementation, and corporate governance, supported by a Master’s in Business Administration. Our partnerships with award-winning R&D labs enable end-to-end NPD within a high-quality and premium standard production framework. The new product development process has been constrained by the partner’s abrupt withdrawal of funds. Manufacturing & fulfilment: All production is via GMP-certified contract manufacturers. Storage, pick/pack, and fulfilment managed by a 3PL warehouse in Brno, including climate-controlled storage and EU-wide distribution. Highly scalable setup enabling rapid expansion across EU markets without physical infrastructure investment. Scale & clients: 18 active B2B partners across New Zealand, the Czech Republic, and the Netherlands. 5 contract manufacturers (GMP / ISO 22716 certified). Initial B2C launch targeting 5,000–7,000 consumers in the first 12 months through the Shopify Plus EU hub. Revenue model: 70% B2B ingredient supply to EU formulators and private-label brands. 30% B2C sales via e-commerce of clean-label, daily effervescent collagen + antioxidant products. Promoter experience: 20+ years in procurement, manufacturing, and international trade. Prior leadership in supply-chain optimisation and product commercialisation across NZ, EU, and CIS markets. We work with contractors who are specialists in the EU legal framework and with a pharmaceutical-certified facility under the supervision of skilled staff to increase our earnings. Both branches operate under the same legal entity.

Operates a pharmaceutical manufacturing unit in Nalagarh, Baddi with WHO-GMP, GLP and ISO certifications. - Produces tablets, capsules, liquid orals, ointments and a CEFA dry powder injection line for government supply, domestic buyers and export clients. - Facility is designed as a general section layout with controlled environments for multiple dosage forms. - Current handling capacity is around 1000 cartons across product categories. - Holds Food and Drug licenses along with active registration on the MCA portal. - Positioned to serve institutional orders and private-label requirements with compliant processes and quality documentation. - Experienced team manages regulatory, technical and quality operations with a focus on international standards. - The business faced legal issues five years ago related to the manufacturing of COVID vaccines. Since then, the charges have been dropped, and it is now legally clear to operate.

The business operates in the pharma marketing and medical equipment wholesale industry, serving as super stockists and channel partners for various healthcare brands in Telangana. - Employing a dedicated team of 4 full-time staff and an additional 8 contract workers, the business effectively manages operations and supports its extensive product range. - The product offerings include a diverse selection of healthcare and medical devices such as ECG machines, surgical equipment, diagnostic strips, and hospital furniture, catering to various medical needs. - Customers include healthcare providers, hospitals, clinics, pharmacies, and individual patients, primarily focusing on improving patient care and recovery management. - Revenue is generated through the sale of top-selling items, particularly generic pharmaceuticals and medical devices like ICU monitors and ECG machines. - The business is legally registered with an LLP certificate of incorporation and holds a GST certificate, ensuring compliance with regulatory standards in India.

Operates a medicine wholesale business supplying pharmaceutical products to local vendors and small retailers. - Serves a steady customer base of around 146 buyers with recurring procurement needs. - Procures medicines from major brands and distributes them directly to local vendors at competitive rates. - Functions as a reliable link in the supply chain for fast-moving pharmaceutical items and essential healthcare products. - Holds a valid GST certification and is registered with the MCA, ensuring compliant operations.

Community-focused herbal medical shop in Khilkhet, Dhaka, specialized in natural and herbal products, addressing health needs with a unique approach. - Offers a wide range of products including herbal medicines, Ayurvedic items, beauty products, and basic health supplies to promote holistic well-being. - Provides home delivery services, making it convenient for customers, especially those in rural areas, to access affordable healthcare solutions. - Conducts health consultations to educate customers on the benefits of natural remedies, enhancing overall customer trust and loyalty. - Targets a diverse customer base, with a focus on individuals with long-term illnesses, skin problems, gastric issues, hormonal concerns, and general health needs. - Generates an average monthly sales of 1,60,000 BDT with a net profit of approximately 50,000 BDT per month, showcasing strong financial stability. - Supports local families by offering affordable healthcare solutions and aims to create a sustainable income source for the owner’s family through community-centered efforts. - Holds a valid trade license, ensuring compliance with local regulations and enhancing business credibility in the pharmaceutical sector.

Pharmaceutical marketing company specializing in general antibiotics and related healthcare products. - Operates as a marketing-driven business with all manufacturing outsourced to certified pharmaceutical producers. - Actively trades and distributes products across Bihar through a network of medical representatives and distributors. - Focused on ensuring product quality, availability, and affordability in the regional pharmaceutical market. - Registered under the Ministry of Corporate Affairs (MCA), ensuring compliance with industry and legal standards.

Upcoming pharmaceutical marketing company focused on herbal, mental health, and botox-related product segments. - Operates as a marketing-led business with manufacturing outsourced to certified third-party producers. - Currently in the pre-revenue stage, preparing to launch a range of specialized pharma and wellness products. - Operations are expected to commence within 3–6 months. - Registered under the Ministry of Corporate Affairs (MCA), ensuring full legal and operational compliance.

The company is engaged in the business of haemostatic medicines, contraceptives, and calcium tablets. - We do not manufacture the products ourselves and rely on a third-party manufacturer. - Our business operates on a B2B model, selling products to stockists. - Currently, we have 19 stockist clients. - Revenue is generated primarily through bulk sales. - The company is a private limited entity with GST and MSME registration. - We are not USFDA approved.

• Authorized distributor for 5–6 pharmaceutical brands. • Top-selling products include IV fluids, salines, and injectables. • Also supplies medicines, surgical items, and other products as per institutional orders. • Key clients include 5 central government hospitals. • Operates with contractual employees for flexibility in fulfilling large orders. • Holds a valid Drug License.